Managing patients with carcinoma of unknown primary: A single UK centre experience

Date 28 June 2017
Event ESMO World Congress on Gastrointestinal Cancer 2017
Session ESMO World Congress on Gastrointestinal Cancer 2017
Topics Carcinoma of Unknown Primary Site (CUP)
Presenter Laura Jaques
Citation Annals of Oncology (2017) 28 (suppl_3): iii13-iii136. 10.1093/annonc/mdx261
Authors L. Jaques, F. Haque, G. Bozas
  • /


In the United Kingdom between 2006-10, 57% of patients with Malignancy of Unknown Origin (MUO) and Carcinoma of Unknown Primary (CUP) presented via the emergency route with a dismal survival rate of 10% at 6 months.1 In response, National Institute of Health and Clinical Excellence (NICE) published a guideline in July 2010 2 outlining the preferred way of managing these patients through the formation of a CUP Multi-disciplinary team(MDT) in UK hospitals. Hull & East Yorkshire NHS Trust have had the MDT running for last 3 years and here we present our first 12 month audit.